A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

Clinical trial NCT05695248 · COMPLETED

Trial details

NCT number: NCT05695248
Sponsor: Astria Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2023-02-21
Primary completion: 2025-03-13
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.